Earnings History Data for BridgeBio Oncology Therapeutics, Inc (BBOT) - NYSE NASDAQ
To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.
See the full list of available companies here.
BridgeBio Oncology Therapeutics, Inc
BridgeBio Oncology Therapeutics is a clinical-stage biopharmaceutical company advancing a next-generation pipeline of novel small molecule therapeutics targeting RAS and PI3K? malignancies. BridgeBio Oncology Therapeutics, formerly known as Helix Acquisition Corp. II, is based in SOUTH SAN FRANCISCO.
| Release Date | Time | Est. Time | Symbol | Name | Market Cap (M) | Rep. EPS | Est. EPS | Last years EPS | SeekingAlpha Headline | Price | Change | Ext. Hours Price | Ext. Hours Change | 52 Week Range | Volume | Avg. Volume | Ext. Hours Volume | Top Mover |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12-11-2025 | PM | BBOT | BridgeBio Oncology Therapeutics, Inc | 1,005 | -1.03 | -0.34 | 0.00 | BridgeBio Oncology Therapeutics, Inc. GAAP EPS of -$1.03 [11/13/2025 9:45 AM] |
12.29 | -0.34 (-2.69%) |
12.63 | 0.0 (0.00%) |
8.50 - 13.46 | 44,796 | 130,000 | 1,448 | ||